Trial · NCT02549170
Adverse events190
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 190
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain upper | Gastrointestinal disorders | Epoch 1: Placebo With rHuPH20 | 0 | 70 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Epoch 1: HYQVIA/HyQvia | 0 | 62 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Epoch 2: E1: Placebo Relapse - E2: GGL/KIOVIG | 0 | 16 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Epoch 2: E1: HYQVIA Relapse - E2: GGL/KIOVIG | 1 | 4 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Epoch 2: E1: Placebo Relapse - E2: GAMMUNEX-C | 0 | 1 | |
| other | Anaemia | Blood and lymphatic system disorders | Epoch 1: Placebo With rHuPH20 | 1 | 70 | |
| other | Anaemia | Blood and lymphatic system disorders | Epoch 1: HYQVIA/HyQvia | 0 | 62 | |
| other | Anaemia | Blood and lymphatic system disorders | Epoch 2: E1: Placebo Relapse - E2: GGL/KIOVIG | 1 | 16 | |
| other | Anaemia | Blood and lymphatic system disorders | Epoch 2: E1: HYQVIA Relapse - E2: GGL/KIOVIG | 0 | 4 | |
| other | Anaemia | Blood and lymphatic system disorders | Epoch 2: E1: Placebo Relapse - E2: GAMMUNEX-C | 0 | 1 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Epoch 1: Placebo With rHuPH20 | 2 | 70 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Epoch 1: HYQVIA/HyQvia | 4 | 62 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Epoch 2: E1: Placebo Relapse - E2: GGL/KIOVIG | 0 | 16 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Epoch 2: E1: HYQVIA Relapse - E2: GGL/KIOVIG | 0 | 4 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Epoch 2: E1: Placebo Relapse - E2: GAMMUNEX-C | 0 | 1 | |
| other | Benign prostatic hyperplasia | Reproductive system and breast disorders | Epoch 1: Placebo With rHuPH20 | 1 | 70 | |
| other | Benign prostatic hyperplasia | Reproductive system and breast disorders | Epoch 1: HYQVIA/HyQvia | 0 | 62 | |
| other | Benign prostatic hyperplasia | Reproductive system and breast disorders | Epoch 2: E1: Placebo Relapse - E2: GGL/KIOVIG | 0 | 16 | |
| other | Benign prostatic hyperplasia | Reproductive system and breast disorders | Epoch 2: E1: HYQVIA Relapse - E2: GGL/KIOVIG | 0 | 4 | |
| other | Benign prostatic hyperplasia | Reproductive system and breast disorders | Epoch 2: E1: Placebo Relapse - E2: GAMMUNEX-C | 1 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02549170/events